What is Universe Pharmaceuticals Return-on-Tangible-Asset?
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Universe Pharmaceuticals's annualizedNet Income for the quarter that ended in Sep. 2023 was $-10.90 Mil. Universe Pharmaceuticals's average total tangible assets for the quarter that ended in Sep. 2023 was $61.67 Mil. Therefore, Universe Pharmaceuticals's annualized Return-on-Tangible-Asset for the quarter that ended in Sep. 2023 was -17.67%.
The historical rank and industry rank for Universe Pharmaceuticals's Return-on-Tangible-Asset or its related term are showing as below:
UPC'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -13.51 Med: 25.11 Max: 33.15
Current: -10.12
During the past 6 years, Universe Pharmaceuticals's highest Return-on-Tangible-Asset was 33.15%. The lowest was -13.51%. And the median was 25.11%.
UPC's Return-on-Tangible-Asset is ranked worse than 69.07% of 1083
companies
in the Drug Manufacturers industry
Industry Median: 1.6
vs UPC: -10.12
Universe Pharmaceuticals Return-on-Tangible-Asset Historical Data
The historical data trend for Universe Pharmaceuticals's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Universe Pharmaceuticals's Return-on-Tangible-Asset
For the Drug Manufacturers - Specialty & Generic subindustry, Universe Pharmaceuticals's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Universe Pharmaceuticals's Return-on-Tangible-Asset Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Universe Pharmaceuticals's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Universe Pharmaceuticals's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Sep. 2023) net income data.
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Universe Pharmaceuticals Return-on-Tangible-Asset Related Terms
Thank you for viewing the detailed overview of Universe Pharmaceuticals's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Universe Pharmaceuticals (Universe Pharmaceuticals) Business Description
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
UPC has been successfully added to your 